Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Chong Kun Dang Pharmaceutical Corp.

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 2
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Biopharma
  • Life Science

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Chong Kun Dang Pharmaceutical Corp.:
Typical Co-investors
Chong Kun Dang Pharmaceutical Corp. is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Chong Kun Dang Pharmaceutical Corp.:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Asheville Angels Asheville, North Carolina, United States
Breakout Labs California, San Francisco, United States
Fuxi Touzi China, Ningbo, Zhejiang
GNI Group -
GP Capital China, Shanghai, Shanghai
Group8 -
Invariantes Fund Guatemala, Guatemala City
Investment Management Corporation of Ontario Canada, Ontario, Toronto
John Lewis & Partners England, London, United Kingdom
M&L Healthcare Investments -
Mack-Cali Realty Corporation Edison, New Jersey, United States
MAD Ventures British Columbia, Canada, Victoria
MAN Truck & Bus Bayern, Germany, Munich
QianMing Capital China, Shanghai
Redhawk VC Alabama, Birmingham, United States
StartupXseed Ventures Bangalore, India, Karnataka
Tokio Marine Investment Services Japan, Tokyo
TOWA INVESTMENT Hokkaido Prefecture, Japan, Sapporo
Yamcom Holdings BV Afula, Israel, North District

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

G+FLAS Life Sciences

Biopharma
Biotechnology
Life Science
$10M31 Jul 2019 South Korea, Gangwon-do, South Korea

BIOMx

Biotechnology
Health Care
Therapeutics
$32M20 Feb 2019 Israel, North District, Israel

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Chong Kun Dang Pharmaceutical Corp.?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 21M
Peak activity year 2019
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

G+FLAS Life Sciences

Biopharma
Biotechnology
Life Science
$10M31 Jul 2019 South Korea, Gangwon-do, South Korea

BIOMx

Biotechnology
Health Care
Therapeutics
$32M20 Feb 2019 Israel, North District, Israel
Crunchbase icon

Content report

The following text will be sent to our editors: